Literature DB >> 23764209

Frailty consensus: a call to action.

John E Morley1, Bruno Vellas, G Abellan van Kan, Stefan D Anker, Juergen M Bauer, Roberto Bernabei, Matteo Cesari, W C Chumlea, Wolfram Doehner, Jonathan Evans, Linda P Fried, Jack M Guralnik, Paul R Katz, Theodore K Malmstrom, Roger J McCarter, Luis M Gutierrez Robledo, Ken Rockwood, Stephan von Haehling, Maurits F Vandewoude, Jeremy Walston.   

Abstract

Frailty is a clinical state in which there is an increase in an individual's vulnerability for developing increased dependency and/or mortality when exposed to a stressor. Frailty can occur as the result of a range of diseases and medical conditions. A consensus group consisting of delegates from 6 major international, European, and US societies created 4 major consensus points on a specific form of frailty: physical frailty. 1. Physical frailty is an important medical syndrome. The group defined physical frailty as "a medical syndrome with multiple causes and contributors that is characterized by diminished strength, endurance, and reduced physiologic function that increases an individual's vulnerability for developing increased dependency and/or death." 2. Physical frailty can potentially be prevented or treated with specific modalities, such as exercise, protein-calorie supplementation, vitamin D, and reduction of polypharmacy. 3. Simple, rapid screening tests have been developed and validated, such as the simple FRAIL scale, to allow physicians to objectively recognize frail persons. 4. For the purposes of optimally managing individuals with physical frailty, all persons older than 70 years and all individuals with significant weight loss (>5%) due to chronic disease should be screened for frailty.
Copyright © 2013 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23764209      PMCID: PMC4084863          DOI: 10.1016/j.jamda.2013.03.022

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  95 in total

1.  Contribution of frailty markers in explaining differences among individuals in five samples of older persons.

Authors:  Nadia Sourial; Howard Bergman; Sathya Karunananthan; Christina Wolfson; Jack Guralnik; Hélène Payette; Luis Gutierrez-Robledo; Dorly J H Deeg; John D Fletcher; Maria T E Puts; Bin Zhu; François Béland
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-28       Impact factor: 6.053

2.  Sarcopenia with limited mobility: an international consensus.

Authors:  John E Morley; Angela Marie Abbatecola; Josep M Argiles; Vickie Baracos; Juergen Bauer; Shalender Bhasin; Tommy Cederholm; Andrew J Stewart Coats; Steven R Cummings; William J Evans; Kenneth Fearon; Luigi Ferrucci; Roger A Fielding; Jack M Guralnik; Tamara B Harris; Akio Inui; Kamyar Kalantar-Zadeh; Bridget-Anne Kirwan; Giovanni Mantovani; Maurizio Muscaritoli; Anne B Newman; Filippo Rossi-Fanelli; Giuseppe M C Rosano; Ronenn Roubenoff; Morris Schambelan; Gerald H Sokol; Thomas W Storer; Bruno Vellas; Stephan von Haehling; Shing-Shing Yeh; Stefan D Anker
Journal:  J Am Med Dir Assoc       Date:  2011-07       Impact factor: 4.669

3.  Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

Authors:  Danijela Gnjidic; Sarah N Hilmer; Fiona M Blyth; Vasi Naganathan; Louise Waite; Markus J Seibel; Andrew J McLachlan; Robert G Cumming; David J Handelsman; David G Le Couteur
Journal:  J Clin Epidemiol       Date:  2012-06-27       Impact factor: 6.437

Review 4.  Frailty in the older surgical patient: a review.

Authors:  Judith S L Partridge; Danielle Harari; Jugdeep K Dhesi
Journal:  Age Ageing       Date:  2012-03       Impact factor: 10.668

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

6.  Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation.

Authors:  Jean Woo; Jason Leung; John E Morley
Journal:  J Am Geriatr Soc       Date:  2012-08-02       Impact factor: 5.562

7.  Measurement properties of the Groningen Frailty Indicator in home-dwelling and institutionalized elderly people.

Authors:  Lilian L Peters; Han Boter; Erik Buskens; Joris P J Slaets
Journal:  J Am Med Dir Assoc       Date:  2012-05-12       Impact factor: 4.669

8.  A frailty instrument for primary care: findings from the Survey of Health, Ageing and Retirement in Europe (SHARE).

Authors:  Roman Romero-Ortuno; Cathal D Walsh; Brian A Lawlor; Rose Anne Kenny
Journal:  BMC Geriatr       Date:  2010-08-24       Impact factor: 3.921

Review 9.  Frailty in primary care: a review of its conceptualization and implications for practice.

Authors:  Alethea Lacas; Kenneth Rockwood
Journal:  BMC Med       Date:  2012-01-11       Impact factor: 8.775

10.  Validation and comparison of two frailty indexes: The MOBILIZE Boston Study.

Authors:  Dan K Kiely; L Adrienne Cupples; Lewis A Lipsitz
Journal:  J Am Geriatr Soc       Date:  2009-07-21       Impact factor: 5.562

View more
  837 in total

1.  Delaying and reversing frailty: a systematic review of primary care interventions.

Authors:  John Travers; Roman Romero-Ortuno; Jade Bailey; Marie-Therese Cooney
Journal:  Br J Gen Pract       Date:  2018-12-03       Impact factor: 5.386

Review 2.  Connecting Age-Related Biological Decline to Frailty and Late-Life Vulnerability.

Authors:  Jeremy D Walston
Journal:  Nestle Nutr Inst Workshop Ser       Date:  2015-10-20

3.  Nutritional Care Needs in Elderly Residents of Long-Term Care Institutions: Potential Implications for Policies.

Authors:  A Pezzana; E Cereda; P Avagnina; G Malfi; E Paiola; Z Frighi; I Capizzi; E Sgnaolin; M L Amerio
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

4.  Frailty and Mortality Outcomes in Cognitively Normal Older People: Sex Differences in a Population-Based Study.

Authors:  Mairead M Bartley; Yonas E Geda; Teresa J H Christianson; V Shane Pankratz; Rosebud O Roberts; Ronald C Petersen
Journal:  J Am Geriatr Soc       Date:  2016-01       Impact factor: 5.562

5.  What Do We Mean by Accumulation? Advancing Conceptual Precision for a Core Idea in Gerontology.

Authors:  Kenneth F Ferraro; Patricia M Morton
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2018-01-11       Impact factor: 4.077

Review 6.  Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era.

Authors:  Alex Friedlaender; Giuseppe Luigi Banna; Lucio Buffoni; Alfredo Addeo
Journal:  Curr Oncol Rep       Date:  2019-11-25       Impact factor: 5.075

7.  FRAIL Questionnaire Screening Tool and Short-Term Outcomes in Geriatric Fracture Patients.

Authors:  Lauren Jan Gleason; Emily A Benton; M Loreto Alvarez-Nebreda; Michael J Weaver; Mitchel B Harris; Houman Javedan
Journal:  J Am Med Dir Assoc       Date:  2017-08-31       Impact factor: 4.669

8.  Prevalence of morphometric vertebral fractures in old men and the agreement between different methods in the city of Recife, Brazil.

Authors:  Carla Nubia Borges; Juliana Maia de Almeida; Denise Lima; Marcelo Cabral; Francisco Bandeira
Journal:  Rheumatol Int       Date:  2014-05-08       Impact factor: 2.631

Review 9.  Comparative Approaches to Understanding the Relation Between Aging and Physical Function.

Authors:  Jamie N Justice; Matteo Cesari; Douglas R Seals; Carol A Shively; Christy S Carter
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-04-23       Impact factor: 6.053

10.  Handgrip Strength and Timed Up-and-Go (TUG) Test are Predictors of Short-Term Mortality among Elderly in a Population-Based Cohort in Singapore.

Authors:  K Y Chua; W S Lim; X Lin; J-M Yuan; W-P Koh
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.